BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10721069)

  • 1. Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy.
    Jović NJ; Mirković D; Majkić-Singh N; Milovanović DD
    Adv Exp Med Biol; 1999; 467():297-302. PubMed ID: 10721069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS; Hoppu K; Nergårdh A; Boreus L
    Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
    Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
    PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of lamotrigine and other antiepileptic drugs in paediatric patients at a Malaysian hospital.
    Ab Rahman AF; Ibrahim MI; Ismail HI; Seng TB
    Pharm World Sci; 2005 Oct; 27(5):403-6. PubMed ID: 16341748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage?
    Morris RG; Black AB; Lam E; Westley IS
    Ther Drug Monit; 2000 Dec; 22(6):656-60. PubMed ID: 11128232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
    Aberg LE; Bäckman M; Kirveskari E; Santavuori P
    Epilepsia; 2000 Oct; 41(10):1296-302. PubMed ID: 11051125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response.
    Bartoli A; Guerrini R; Belmonte A; Alessandrì MG; Gatti G; Perucca E
    Ther Drug Monit; 1997 Jun; 19(3):252-60. PubMed ID: 9200763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Guo CY; Ronen GM; Atkinson SA
    Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does lamotrigine influence valproate concentrations?
    Mataringa MI; May TW; Rambeck B
    Ther Drug Monit; 2002 Oct; 24(5):631-6. PubMed ID: 12352935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effectiveness of Lamotrigine and Its Blood Levels for Pediatric Epilepsy.
    Iwasaki T; Toki T; Nonoda Y; Ishii M
    Am J Ther; 2017; 24(5):e524-e531. PubMed ID: 26295614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
    Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
    Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
    Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
    Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral contraceptives on lamotrigine levels depends on comedication.
    Wegner I; Wilhelm AJ; Lambrechts DA; Sander JW; Lindhout D
    Acta Neurol Scand; 2014 Jun; 129(6):393-8. PubMed ID: 24571554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
    Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.
    Coppola G; Pascotto A
    Brain Dev; 1997 Sep; 19(6):398-402. PubMed ID: 9339867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of uridine diphosphate glucuronosyltransferase inducers and inhibitors on the plasma lamotrigine concentration in pediatric patients with refractory epilepsy.
    Yamamoto Y; Takahashi Y; Imai K; Ikeda H; Takahashi M; Nakai M; Inoue Y; Kagawa Y
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):214-20. PubMed ID: 25825021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.